TNF Pharmaceuticals Statistics
Total Valuation
TNFA has a market cap or net worth of $2.23 million. The enterprise value is -$6.28 million.
Important Dates
The last earnings date was Friday, April 11, 2025, after market close.
| Earnings Date | Apr 11, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
TNFA has 10.13 million shares outstanding. The number of shares has increased by 58.00% in one year.
| Current Share Class | 10.13M |
| Shares Outstanding | 10.13M |
| Shares Change (YoY) | +58.00% |
| Shares Change (QoQ) | +19.05% |
| Owned by Insiders (%) | 0.14% |
| Owned by Institutions (%) | 1.44% |
| Float | 10.11M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| Forward PS | n/a |
| PB Ratio | 0.08 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 1.40, with a Debt / Equity ratio of 0.00.
| Current Ratio | 1.40 |
| Quick Ratio | 1.27 |
| Debt / Equity | 0.00 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -169.93% and return on invested capital (ROIC) is -39.29%.
| Return on Equity (ROE) | -169.93% |
| Return on Assets (ROA) | -27.56% |
| Return on Invested Capital (ROIC) | -39.29% |
| Return on Capital Employed (ROCE) | -58.83% |
| Revenue Per Employee | n/a |
| Profits Per Employee | -$13.58M |
| Employee Count | 2 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -91.99% in the last 52 weeks. The beta is 2.48, so TNFA's price volatility has been higher than the market average.
| Beta (5Y) | 2.48 |
| 52-Week Price Change | -91.99% |
| 50-Day Moving Average | 0.36 |
| 200-Day Moving Average | 1.18 |
| Relative Strength Index (RSI) | 35.86 |
| Average Volume (20 Days) | 2,712,522 |
Short Selling Information
The latest short interest is 1.03 million, so 10.20% of the outstanding shares have been sold short.
| Short Interest | 1.03M |
| Short Previous Month | 936,238 |
| Short % of Shares Out | 10.20% |
| Short % of Float | 10.22% |
| Short Ratio (days to cover) | 4.97 |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -8.66M |
| Pretax Income | -12.29M |
| Net Income | -27.16M |
| EBITDA | n/a |
| EBIT | -8.66M |
| Earnings Per Share (EPS) | -$11.15 |
Full Income StatementBalance Sheet
The company has $8.52 million in cash and $10,579 in debt, giving a net cash position of $8.51 million or $0.84 per share.
| Cash & Cash Equivalents | 8.52M |
| Total Debt | 10,579 |
| Net Cash | 8.51M |
| Net Cash Per Share | $0.84 |
| Equity (Book Value) | 14.72M |
| Book Value Per Share | 2.87 |
| Working Capital | 2.71M |
Full Balance SheetCash Flow
| Operating Cash Flow | -8.98M |
| Capital Expenditures | n/a |
| Free Cash Flow | n/a |
| FCF Per Share | n/a |
Full Cash Flow StatementMargins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |